Navigation Links
PharmaVentures' Client Sanofi Wins Scrip 'Outsourcing Deal of the Year Award'
Date:1/12/2012

OXFORD, English, January 12, 2012 /PRNewswire/ --

PharmaVentures announced today that it was delighted to play an advisory role in the Sanofi - Covance deal which won Scrip's 'Outsourcing Deal of the Year 2011'.

The judges described the deal as 'impressive' as it was "one the largest and most comprehensive R&D alliances in the history of the pharmaceutical and CRO industry".Under the terms of the agreement, Sanofi retains access to some of the capabilities that were divested to Covance as part of a long-term strategic alliance. Covance will provide Sanofi with an up to 10-year sole source relationship for central lab services.

Kevin Bottomley, Head of Transactions at PharmaVentures who was lead advisor to Sanofi on the deal said:  "This is a great recognition for Sanofi as this was a ground-breaking deal which ultimately supports both its overall strategic intent."

Fintan Walton, Chief Executive of PharmaVentures said: "Deal making has become both more complex and more sophisticated. This Scrip Award recognises how PharmaVentures' clients are reaching new heights in deal making. We are delighted to be advisors to this award winning deal."

Over the years PharmaVentures has built considerable experience in the M&A field including divestments of manufacturing and R&D businesses.

Note to Editors

If you wish to write an article, please contact us for any further information you require.

About PharmaVentures

PharmaVentures (http://www.pharmaventures.com) is an international healthcare advisory group providing leadership in all aspects of deals and alliances, from strategy formulations to implementation. The company occupies a special position in the global marketplace because of our track record of successful outcomes, resulting from our unique insight into the world of deal making, our internationally recognised analytical and valuation capabilities, our own proprietary deal making database PharmaDeals®(http://www.pharmadeals.net), containing over 42,000 deal records, and our extensive business relationship network and our outstanding success in M&A transactions.

Our Services Cover:

  • Valuation (for licensing, acquisitions, divestments, fund raising & expert testimonies)
  • Licensing (In and Out licensing)
  • M&A (Companies & Assets)
  • Strategy (commercialisation, deal strategy, due diligence, market entry)
  • Expert Testimony (Patent Infringement, Deal Disagreements, Taxation, Determining Damages)

Now in its 20th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.

PharmaDeals® and PharmaVentures® are registered Trade Marks of PharmaVentures Ltd.

For further information, contact:
Kevin Bottomley
Head of Transactions
+44 1865-332700
Kevin.Bottomley@pharmaventures.com



'/>"/>
SOURCE PharmaVentures Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaVentures Appoints Andy Smith as Head of Corporate Finance
2. PharmaVentures Engaged by Astex Therapeutics to Assist in the Divestment of US Facility
3. Matrix Corporate Capital and PharmaVentures Announce the Signing of a Memorandum of Understanding (MOU)
4. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
5. PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
6. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
7. Netsmart Clients to Receive Nearly $2 Million in Meaningful Use EHR Incentive Payments
8. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
9. Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
10. Sermo Announces New Client Center with Advanced Mining and Monitoring of Organic Physician Dialog
11. bj-diagnostik Renforce le Conseil-client Pour les Tests ADN de Fratrie et de Paternit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2017)... ... February 25, 2017 , ... The STARR Coalition ... effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders ... and patients’ mental health well-being. , Both organizations are dedicated to promoting patient ...
(Date:2/24/2017)... ... February 24, 2017 , ... A study recently published in ... ambulatory surgery center (ASC) with satisfactory clinical and patient-reported outcomes, when compared to ... , Jake Lubinski, president of AxioMed, commented on the recent publication, stating, “We ...
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from her ... several cities, she gained a number of delicious recipes and new techniques to share ... South Africa’s Western Cape province. It is internationally renowned for its incredible wine ...
Breaking Biology Technology:
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/22/2017)... With the biometrics market to exceed ... technologies that innovative and agile startups must incorporate ... the changing competitive landscape: multifactor authentication (MFA), point-of-sale ... "Companies can no longer afford to cut ... Dimitrios Pavlakis , Industry Analyst at ABI Research. ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):